相关实验视频

Updated: Jul 21, 2025

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

肌酸激酶MB异酶是氨基缩侧面硬化症的补充生物标志物

Natsinee Kittipeerapat¹, Rachel Fabian¹, Sarah Bernsen¹

¹Department of Neurodegenerative Diseases/Neurology, University Hospital Bonn, 53127 Bonn, Germany.

International journal of molecular sciences

|July 29, 2023

概括

肌酸激酶单酶MB (CK-MB) 可能作为一种新的肌缩侧面硬化症 (ALS) 的生物标志物. 在ALS患者中CK-MB水平升高与疾病进展和特定的临床特征相关.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
临床诊断临床诊断临床诊断

背景情况:

肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病,治疗选择有限.
对于对ALS诊断,治疗试验和疾病监测而言,迫切需要可靠的生物标志物.
目前对ALS的诊断和预后工具需要改进.

研究的目的:

系统地调查ALS患者的现实世界队列中的肌酸激酶异酶MB (CK-MB).
评估CK-MB在区分ALS与其他神经退行性疾病方面的诊断性能.
评估CK-MB水平与ALS临床参数和疾病进展的相关性.

主要方法:

追溯分析了194名患者的数据,其中包括130名ALS患者和64名疾病对照者 (PLS,BFS,HD,AD).
测量所有参与者的血清CK-MB水平.
对CK-MB水平与临床数据的相关性分析,包括ALSFRS-R,发病类型和心脏托罗邦素T (cTnT).

主要成果:

在超过一半的ALS患者中,CK-MB升高.
与其他神经退行性疾病相比,在脊柱发病的ALS中观察到显著更高的CK-MB水平.
较高的基线CK-MB水平与较慢的功能衰退和特定的圆柱体呈现相关 (ALSFRS-R).
CK-MB的升高显示与心脏托罗邦尼T (cTnT) 的相关性.

结论:

血清CK-MB可以作为ALS诊断的补充生物标志物,有助于与模仿者和其他神经退行性疾病的差异化.
CK-MB水平显示出提供有关ALS疾病攻击性和表型表现的预后信息的潜力.
进一步研究CK-MB作为ALS生物标志物是有必要的,以改善患者管理和治疗开发.

关键词:

这是一种CK-MB异酶.肌缩侧面硬化症 (ALS) 是一种疾病.生物标志物生物标志物肌氨酸激酶 (CK) 的使用预测价值的预测价值是什么

更多相关视频

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Assaying the Kinase Activity of LRRK2 in vitro

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Cross-bridge Cycle

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.